http://www.assurerxhealth.com/press_releases Liftoff to Space Exploration. en-us JustPageIt 5 http://www.assurerxhealth.com/index.php?id=232 AssureRx Health, Inc. today announced it has launched a personalized medicine test for the growing number of children and adults diagnosed with attention deficit hyperactivity disorder (ADHD). The new pharmacogenomic test can assist clinicians with important medication decisions that result from genomic differences in how individual patients tolerate ADHD medications. Mon, 07 May 2012 00:00:00 GMT http://www.assurerxhealth.com/press_releases#232 http://www.assurerxhealth.com/index.php?id=230 The Angel Capital Association, a trade association of leading angel investment groups in North America, recognized AssureRx Health Inc. as an innovative leader in personalized medicine technology with the 2012 Luis Villalobos Award. Mon, 12 Mar 2012 00:00:00 GMT http://www.assurerxhealth.com/press_releases#230 http://www.assurerxhealth.com/index.php?id=228 AssureRx Health, Inc., today announced that it has secured an $8 million Term and Revolving Credit Facility that provides additional capital to support increasing clinical adoption of GeneSightRx and to finance multiple new products scheduled for launch in 2012. The credit facilities were secured through the company’s new banking partner, Silicon Valley Bank, a premier bank for venture-backed technology companies. Tue, 31 Jan 2012 00:00:00 GMT http://www.assurerxhealth.com/press_releases#228 http://www.assurerxhealth.com/index.php?id=227 AssureRx Health, Inc., announced today that its laboratory has been certified by the New York State Department of Health, ensuring that patients throughout New York State have access to the GeneSightRx® testing program through their personal prescribing clinician. With the approval from New York State, the AssureRx Health laboratory is now certified to analyze DNA samples for pharmacogenomic testing in all 50 U.S. states. Tue, 24 Jan 2012 00:00:00 GMT http://www.assurerxhealth.com/press_releases#227 http://www.assurerxhealth.com/index.php?id=220 The enhancements include the addition of six new psychotropic medications to the current panel of 26 medications, expanded support for mobile devices, and new capabilities to fast-track research discoveries into clinical practice. Tue, 17 Jan 2012 00:00:00 GMT http://www.assurerxhealth.com/press_releases#220 http://www.assurerxhealth.com/index.php?id=219 AssureRx Health, Inc., and the City of Mason, Ohio, today announced an agreement to locate its new company headquarters and dry laboratory at the Mason Community Center to accommodate the company’s employee growth and increasing demand for its pharmacogenetic test, GeneSightRx®. The new 10,000 square-foot office space can accommodate more than 100 employees. Wed, 12 Oct 2011 00:00:00 GMT http://www.assurerxhealth.com/press_releases#219 http://www.assurerxhealth.com/index.php?id=218 AssureRx Health, Inc., today announced three additions to its senior management team. These additions coincide with increasing adoption of GeneSightRx® pharmacogenetic testing aimed at assisting healthcare providers manage side effects and drug selection for patients requiring antidepressant or antipsychotic medication therapy. Wed, 07 Sep 2011 00:00:00 GMT http://www.assurerxhealth.com/press_releases#218 http://www.assurerxhealth.com/index.php?id=209 AssureRx Health, Inc., today announced two presentations on the clinical practice of utilizing its pharmacogenetic test, GeneSightRx®, at the 164th Annual Meeting of the American Psychiatric Association (APA) in Honolulu, May 14-18, 2011. Key activities include a free GeneSightRx testing program for the first 200 physicians who visit AssureRx’s booth at the conference. Thu, 12 May 2011 00:00:00 GMT http://www.assurerxhealth.com/press_releases#209 http://www.assurerxhealth.com/index.php?id=208 Program is Largest Commercial Pilot of AssureRx's GeneSightRx® Test to Help Physicians Select Appropriate Medications for Individual Patients with Neuropsychiatric Disorders Wed, 11 May 2011 00:00:00 GMT http://www.assurerxhealth.com/press_releases#208 http://www.assurerxhealth.com/index.php?id=187 Personalized Medicine Company to Expand Marketing and Product Development for Neuropsychiatric Pharmacogenetics Fri, 25 Mar 2011 00:00:00 GMT http://www.assurerxhealth.com/press_releases#187